HGF inhibits BMP-induced osteoblastogenesis: Implications for the bone disease in multiple myeloma.

被引：0
|
作者：
Standal, Therese
Abildgaard, Niels
Fagerli, Unn-Merete
Stordal, Berit
Hjertner, Oyvind
Borset, Magne
Sundan, Anders
机构：
[1] Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway
[2] Odense Univ Hosp, Dept Haematol, DK-5000 Odense, Denmark
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3451.3451
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3451
引用
收藏
页码：985A / 985A
页数：1
相关论文
共 50 条
  • [31] Catecholamines Accelerate BMP-induced Osteoblastic Differentiation and Bone Formation.
    Uemura, T.
    Ohta, Y.
    Nakao, Y.
    Hashimoto, Y.
    Takaoka, K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S275 - S275
  • [32] Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
    Croucher, PI
    Shipman, CM
    Lippitt, J
    Perry, M
    Asosingh, K
    Hijzen, A
    Brabbs, AC
    van Beek, EJR
    Holen, I
    Skerry, TM
    Dunstan, CR
    Russell, GR
    Van Camp, B
    Vanderkerken, K
    BLOOD, 2001, 98 (13) : 3534 - 3540
  • [33] Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
    Croucher, PI
    Shipman, CM
    Perry, M
    Lippitt, J
    Asosingh, K
    van Beek, EJR
    Van Camp, B
    Russell, RGG
    Dunstan, C
    Vanderkerken, K
    BONE, 2001, 28 (05) : S81 - S81
  • [34] Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration
    Kristensen, Ida B.
    Pedersen, Lise
    Ro, Torstein B.
    Christensen, Jacob H.
    Lyng, Maria B.
    Rasmussen, Lars M.
    Ditzel, Henrik J.
    Borset, Magne
    Abildgaard, Niels
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 91 (03) : 196 - 200
  • [35] Evaluation of biochemical markers of bone turnover in multiple myeloma.
    Palermos, J
    Terpos, E
    Boura, X
    Mavrogianni, D
    Tsonos, K
    Meletis, J
    CLINICAL CHEMISTRY, 1999, 45 (06) : A156 - A156
  • [36] Bone mineral density (BMD) in patients with multiple myeloma.
    Hungria, VTM
    Gouveia, CHA
    Malvestiti, LF
    Bianco, AC
    Barros, JC
    Chiattone, CS
    Marone, MMS
    BLOOD, 1995, 86 (10) : 3328 - 3328
  • [37] A morphometric study of bone marrow angiogenesis in multiple myeloma.
    Kavantzas, N
    Korkolopoulou, P
    Anargyrou, K
    Kirtsonis, MC
    Thymara, I
    Terpos, E
    Dimopoulou, M
    Boutsis, D
    Viniou, N
    Plata, E
    Patsouris, E
    Davaris, P
    Pangalis, G
    Yataganas, X
    BLOOD, 2002, 100 (11) : 372B - 372B
  • [38] IL-3 inhibits osteoblast differentiation in multiple myeloma.
    Ehrlich, LA
    Choi, SJ
    Chung, HY
    Roodman, GD
    BLOOD, 2003, 102 (11) : 442A - 442A
  • [39] Allogeneic bone marrow transplantation for advanced multiple myeloma.
    Stoetzer, OJ
    Ledderose, G
    Muth, A
    Ott, B
    Salat, C
    Schmid, C
    Hollburg, W
    Schlemmer, M
    Schmidhuber, S
    Pfannes, W
    Ostermann, H
    Schleuning, M
    Kolb, HJ
    BLOOD, 1999, 94 (10) : 389B - 389B
  • [40] Prognostic value of markers of bone turnover in multiple myeloma.
    Terpos, E
    Szydlo, R
    Hatziharissi, E
    de la Fuente, J
    Viniou, N
    Meletis, J
    Yataganas, X
    Apperley, JF
    Goldman, JM
    Rahemtulla, A
    BLOOD, 2002, 100 (11) : 372B - 373B
12345